Sanofi to pay Lexicon for terminated partnership Acids, Business, Clinical Studies, Diabetes, Diabetic Ketoacidosis, Insulin, Ketones, Partnerships, Shares, Terminations, Type 1 Diabetes Lexicon Pharmaceuticals Inc. said France’s Sanofi SA will pay the Texas-based drugmaker $260 million for the termination of their partnership to develop the diabetes drug Zynquista. Read more September 10, 2019/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2019-09-10 17:05:082019-09-11 13:25:57Sanofi to pay Lexicon for terminated partnership
